Description
🌙 The Ordinary Retinol 1% in Squalane 30ml (Made in Canada)
The Ordinary Retinol 1% in Squalane is a high-strength anti-aging serum designed for experienced retinol users looking to improve skin texture, firmness, and overall skin appearance.
Formulated with 1% Pure Retinol, this powerful treatment helps accelerate skin renewal, visibly reduce fine lines and wrinkles, and improve uneven skin texture. The addition of Squalane helps maintain hydration and minimizes the dryness commonly associated with retinol use.
Its lightweight oil-based formula absorbs comfortably into the skin, making it an ideal addition to your nighttime skincare routine.
🌟 Key Benefits
- Helps reduce fine lines and wrinkles
- Improves skin texture and smoothness
- Promotes firmer-looking skin
- Helps improve uneven skin tone
- Supports skin renewal and rejuvenation
- Contains hydrating squalane to reduce dryness
🌿 Key Ingredients
Retinol (1%)
A powerful Vitamin A derivative that helps improve skin turnover and reduce visible signs of aging.
Squalane
Provides lightweight hydration and helps support the skin barrier.
Antioxidant-Rich Plant Extracts
Help support healthier-looking skin.
🧴 Suitable Skin Type
- Fine Lines & Wrinkles
- Mature Skin
Additional Suitable Skin Types:
- Normal Skin
- Dry Skin
- Combination Skin
Not recommended for beginners, highly sensitive skin, or compromised skin barriers.
📝 How to Use
- Apply a few drops to clean, dry skin in the evening.
- Use after water-based serums and before moisturizer.
- Start with 2–3 nights per week and gradually increase usage.
- Always apply sunscreen during daytime use.
Note: Avoid using alongside other retinoids, strong exfoliating acids, or direct Vitamin C in the same routine.
✅ Key Product Highlights
✔ High-strength 1% Retinol formula
✔ Helps reduce wrinkles and fine lines
✔ Improves skin texture and firmness
✔ Contains hydrating Squalane
✔ Advanced anti-aging treatment
✔ Ideal for experienced retinol users
✔ 30ml bottle
✔ Made in Canada






Reviews
There are no reviews yet.